Presymptomatic Diagnosis with MRI and Adequate Treatment Ameliorate the Outcome after Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Natalizumab (Tysabri(®)) is a monoclonal antibody that prevents inflammatory cells from binding to brain endothelial cells and passing into the brain parenchyma. Natalizumab is a highly effective treatment for relapsing-remitting multiple sclerosis (MS). Progressive multifocal leukoencephalopathy (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindå, Hans, von Heijne, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575071/
https://www.ncbi.nlm.nih.gov/pubmed/23423248
http://dx.doi.org/10.3389/fneur.2013.00011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575071/
https://www.ncbi.nlm.nih.gov/pubmed/23423248
http://dx.doi.org/10.3389/fneur.2013.00011

Ejemplares similares